Literature DB >> 31792915

Myocardial perfusion imaging in cardiac sarcoidosis: A "sine qua non" for prognosis assessment?

Georgios Benetos1, Andreas A Giannopoulos2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31792915     DOI： 10.1007/s12350-019-01964-w

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  3 in total

1.  Scadding revisited: a proposed staging system for cardiac sarcoidosis.

Authors:  Jeffrey S Berman; Praven Govender; Frederick L Ruberg; Michael Mazzini; Edward J Miller
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2014-04-18       Impact factor: 0.670

2.  Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.

Authors:  Wataru Okumura; Tsutomu Iwasaki; Takuji Toyama; Tatsuya Iso; Masashi Arai; Noboru Oriuchi; Keigo Endo; Tomoyuki Yokoyama; Tadashi Suzuki; Masahiko Kurabayashi
Journal:  J Nucl Med       Date:  2004-12       Impact factor: 10.057

3.  18F-FMISO PET/CT detects hypoxic lesions of cardiac and extra-cardiac involvement in patients with sarcoidosis.

Authors:  Sho Furuya; Masanao Naya; Osamu Manabe; Kenji Hirata; Hiroshi Ohira; Tadao Aikawa; Kazuhiro Koyanagawa; Keiichi Magota; Ichizo Tsujino; Toshihisa Anzai; Yuji Kuge; Noriko Oyama-Manabe; Kohsuke Kudo; Tohru Shiga; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2019-12-09       Impact factor: 5.952
  3 in total
  1 in total

1.  Added value gated PET with phase analysis for the detection of scar burden and prognostication in cardiac sarcoidosis?

Authors:  Thomas H Schindler; Adeel Haq; Sudhir Jain
Journal:  J Nucl Cardiol       Date:  2021-01-27       Impact factor: 3.872
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.